Purchase Order HHSN275201600821P
Award Date 9/12/16
Potential Completion Date 9/30/16
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,148,568.17 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The contract was set aside for small businesses and awarded under the Small Business Innovation Research (SBIR) program, Phase I. It is for biomedical (applied/exploratory) research and development, with a period of performance from September 30, 2008, to March 29, 2011. Based...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Myriad RBM, Inc., a subsidiary of Myriad Genetics Inc. The contract has a ceiling value of $64,875.00 and a completion date of September 30, 2014. The contract is for "OTHER FUNCTIONS - CSF ASSAYS TESTING" services and does not have a set-aside designation, indicating open competition. The parent company, Myriad Genetics Inc., is a...
- This federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., is for a Firm Fixed Price Purchase Order of $7,946.32 to provide MYRIAD GENETIC TESTING services. The contract, awarded by the Defense Health Agency, has an ultimate completion date of February 25, 2017. Myriad Genetic Laboratories Inc. is a for-profit company that specializes in genetic testing and precision medicine services. The primary service provided under this contract is the Prolaris...
- This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
- This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...
- Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., was awarded a delivery order valued at $30,000 by the National Cancer Institute on June 25, 2007, with a completion date of September 20, 2007. This firm fixed-price contract, which carries no set-aside designation, involves the delivery of chemical-biological study services to be performed at the awardee's facility in Emigration Canyon, Utah. The National Cancer Institute, part of the National Institutes of Health, funds...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Myriad RBM, Inc. for $7,200.00. The order is for bio marking services, which likely involves providing genetic testing and analysis services to assess the biological markers or genomic characteristics of patient samples. Myriad RBM, Inc. is a subsidiary of the parent company Myriad Genetics Inc., a molecular diagnostics...
- This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- This is a firm-fixed-price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The $95,000.00 contract is for the provision of various genetic testing services, with a focus on Prolaris prostate cancer testing. The contract is a Blanket Purchase Agreement (BPA) call, allowing the Department of Veterans Affairs (VA) to efficiently procure Myriad's specialized genetic testing services across multiple regions....